We analyzed treatment results in regard to survival and local metastasis control.
2
Background: Reliable method to predict lymph node metastasis is not yet available.
3
Purpose: To review the available options of percutaneous ablation of lung metastasis.
4
Outcomes: No recurrence or metastasis occurred during 50 months after the operation.
5
However, no local recurrence or metastasis has been detected 2 months post-surgery.
1
Although uncommon, primary and metastaticneoplasms can occur in the chest wall.
2
Tumor embolism is a rare cause of stroke, occurring with primary or metastaticneoplasms of the lung.
3
The biological heterogeneity of metastaticneoplasms and the production of metastases that are resistant to therapy is the major cause of death from cancer.
1
Background: Tumor angiogenesis is essential for primary and metastatictumor growth.
2
We investigated the hypothesis that ASCs have an inhibitory effect on metastatictumor progression.
3
Bone marrow provides a unique microenvironment favoring the colonization and outgrowth of metastatictumor cells.
4
Conclusions: A metastatictumor was the only independently significant unfavorable factor for local control after SBRT.
5
Methods: Patients undergoing a clinically indicated metastatictumor biopsy were consented to the ongoing METAMORPH registry.
1
One patient had Stage II breast carcinoma; the other had metastaticdisease.
2
The patient died 1 year later due to progression of metastaticdisease.
3
The remaining five patients were believed to be free of metastaticdisease.
4
Several experimental models faithfully recapitulate many important facets of human metastaticdisease.
5
Palliative systemic treatment is the only option for patients with metastaticdisease.